Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
4.75
Dollar change
-0.13
Percentage change
-2.66
%
Index- P/E- EPS (ttm)-1.35 Insider Own19.98% Shs Outstand14.19M Perf Week0.00%
Market Cap67.40M Forward P/E23.75 EPS next Y0.20 Insider Trans3.81% Shs Float11.36M Perf Month-4.04%
Income-19.20M PEG- EPS next Q-0.14 Inst Own66.01% Short Float0.61% Perf Quarter12.83%
Sales116.68M P/S0.58 EPS this Y6.74% Inst Trans-0.81% Short Ratio1.03 Perf Half Y-40.62%
Book/sh5.61 P/B0.85 EPS next Y124.10% ROA-15.08% Short Interest0.07M Perf Year-46.39%
Cash/sh1.20 P/C3.96 EPS next 5Y20.00% ROE-21.83% 52W Range3.37 - 11.98 Perf YTD13.10%
Dividend Est.- P/FCF- EPS past 5Y- ROI-19.71% 52W High-60.35% Beta1.44
Dividend TTM- Quick Ratio1.69 Sales past 5Y4.70% Gross Margin35.11% 52W Low40.95% ATR (14)0.19
Dividend Ex-Date- Current Ratio2.99 EPS Y/Y TTM-237.87% Oper. Margin-6.79% RSI (14)42.69 Volatility3.08% 4.04%
Employees405 Debt/Eq0.26 Sales Y/Y TTM13.92% Profit Margin-16.45% Recom2.00 Target Price6.00
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q-236.70% Payout- Rel Volume0.85 Prev Close4.88
Sales Surprise11.91% EPS Surprise-153.85% Sales Q/Q15.60% EarningsFeb 09 AMC Avg Volume66.98K Price4.75
SMA20-7.14% SMA50-1.61% SMA200-28.93% Trades Volume56,758 Change-2.66%
Date Action Analyst Rating Change Price Target Change
Mar-09-21Upgrade ROTH Capital Neutral → Buy $9 → $15
Feb-12-21Upgrade The Benchmark Company Hold → Buy $10
Aug-10-18Downgrade The Benchmark Company Buy → Hold
Nov-21-17Reiterated The Benchmark Company Buy $12 → $18
Aug-04-17Initiated ROTH Capital Buy $12
May-11-17Reiterated The Benchmark Company Buy $8 → $10
Apr-26-17Upgrade The Benchmark Company Hold → Buy $8
Nov-18-16Downgrade The Benchmark Company Buy → Hold $5
May-06-16Reiterated The Benchmark Company Buy $9.50 → $8.90
Feb-05-16Reiterated Stifel Buy $10 → $9
Feb-13-24 08:49AM
Feb-12-24 10:06PM
Feb-09-24 05:15PM
04:12PM
04:05PM
05:37PM Loading…
Feb-08-24 05:37PM
Jan-24-24 05:38AM
05:19AM
Jan-23-24 11:54PM
Dec-20-23 05:00PM
12:32PM
Dec-19-23 08:21AM
Dec-15-23 08:42AM
05:51AM
Dec-14-23 06:25PM
05:37PM Loading…
05:37PM
10:11AM
08:46AM
Dec-13-23 04:05PM
Dec-06-23 07:00AM
Dec-05-23 01:24PM
02:00AM
Nov-29-23 07:07AM
Nov-20-23 04:06PM
Oct-16-23 06:17PM
Aug-16-23 05:01AM
Aug-10-23 06:42AM
Aug-09-23 05:24PM
04:05PM
04:03PM
08:00AM Loading…
Jul-26-23 08:00AM
Jul-15-23 09:46AM
Jul-12-23 04:10PM
Jul-01-23 08:55AM
Jun-29-23 05:48PM
Jun-17-23 08:25AM
Jun-03-23 08:18AM
May-20-23 08:02AM
May-10-23 05:55PM
04:46PM
04:05PM
May-03-23 03:57PM
Apr-24-23 04:05PM
Apr-19-23 03:25PM
Apr-11-23 04:05PM
Mar-15-23 04:05PM
Mar-10-23 06:51AM
Mar-02-23 06:44AM
Feb-21-23 04:05PM
Feb-14-23 06:23AM
Feb-08-23 05:25PM
04:07PM
04:05PM
Jan-31-23 09:40AM
Jan-27-23 09:39AM
Jan-25-23 04:10PM
Jan-17-23 04:45PM
Jan-14-23 04:37PM
Jan-13-23 07:55AM
Dec-30-22 07:30AM
03:44AM
Dec-16-22 06:28AM
Dec-09-22 11:04AM
Dec-07-22 02:18PM
Dec-02-22 05:45AM
Nov-30-22 05:40PM
05:00PM
04:07PM
04:05PM
Nov-29-22 09:40AM
Nov-21-22 06:18AM
Nov-16-22 04:05PM
Nov-11-22 09:40AM
Oct-24-22 01:19PM
Oct-08-22 08:25AM
Sep-22-22 05:44AM
Sep-21-22 09:40AM
Sep-13-22 09:55AM
Sep-08-22 09:35AM
Sep-05-22 09:40AM
Sep-02-22 09:55AM
Sep-01-22 08:00AM
Aug-19-22 09:40AM
Aug-15-22 04:05PM
Aug-10-22 07:57AM
Jul-28-22 04:05PM
Jul-14-22 06:50AM
Jun-27-22 12:55PM
Jun-16-22 08:56AM
Jun-13-22 11:45AM
May-30-22 11:42AM
May-16-22 11:21AM
May-11-22 06:05PM
04:05PM
May-01-22 08:08AM
Apr-28-22 08:00AM
Apr-27-22 03:03PM
Apr-26-22 05:15PM
Mar-25-22 02:22PM
Mar-04-22 10:18AM
Amtech Systems, Inc. engages in the manufacture of semiconductors and capital equipment. It operates through the Semiconductor and Material and Substrate segments. The Semiconductor segment involves the designing, manufacturing, selling, and servicing of thermal processing equipment and related controls for use by semiconductor manufacturers, and in electronics, automotive, and other industries. The Material and Substrate segment produces consumables and machinery for lapping and polishing materials, such as sapphire substrates, optical components, silicon wafers, and numerous types of crystal materials, ceramics, and metal components. The company was founded by Jong S. Whang in October 1981 and is headquartered in Tempe, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARNREITER MICHAELDirectorMar 01 '24Option Exercise0.004,189022,189Mar 04 05:17 PM
LUDWIG MICHAEL MDirectorMar 01 '24Option Exercise0.004,18907,189Mar 04 05:17 PM
DAIGLE ROBERT CChairman & CEOMar 01 '24Option Exercise0.007,8540108,056Mar 04 05:34 PM
Averick Robert MDirectorMar 01 '24Option Exercise0.004,1890418,189Mar 04 04:01 PM
Averick Robert MDirectorFeb 13 '24Buy4.2120,50086,305414,000Feb 14 04:01 PM
DAIGLE ROBERT CChairman & CEOFeb 13 '24Buy4.213,50014,735103,702Feb 15 04:55 PM
DAIGLE ROBERT CChief Executive OfficerDec 19 '23Buy3.9020,00078,000100,202Dec 19 04:51 PM
DAIGLE ROBERT CChief Executive OfficerDec 18 '23Buy3.9646,000182,16080,202Dec 19 04:51 PM
Averick Robert MDirectorDec 18 '23Buy3.9014,00054,600393,500Dec 20 04:01 PM
DAIGLE ROBERT CChief Executive OfficerAug 25 '23Buy8.604,00034,40034,202Aug 25 05:57 PM
DAIGLE ROBERT CChief Executive OfficerAug 24 '23Buy8.598,25070,86830,202Aug 25 05:57 PM
Averick Robert MDirectorAug 18 '23Buy8.969,00080,64011,000Aug 21 04:02 PM
Averick Robert MDirectorAug 17 '23Buy8.706,50056,550379,500Aug 21 04:02 PM
DAIGLE ROBERT CChief Executive OfficerAug 16 '23Buy8.752,20019,26021,903Aug 16 06:23 PM
DAIGLE ROBERT CChief Executive OfficerAug 15 '23Buy8.752332,03919,703Aug 16 06:23 PM
DAIGLE ROBERT CChief Executive OfficerAug 14 '23Buy9.101,0009,10019,470Aug 15 04:08 PM
DAIGLE ROBERT CChief Executive OfficerAug 14 '23Buy9.004944121,952Aug 16 08:26 PM
DAIGLE ROBERT CChief Executive OfficerAug 11 '23Buy8.9315,386137,39718,470Aug 15 04:08 PM
Averick Robert MDirectorAug 11 '23Buy8.887,50066,600373,000Aug 14 04:01 PM
GARNREITER MICHAELDirectorJul 06 '23Option Exercise7.016,00042,06018,000Jul 07 06:05 PM
Averick Robert MDirectorMay 23 '23Buy8.891,50013,335365,500May 25 04:01 PM
DAIGLE ROBERT CDirectorMay 19 '23Buy8.75847353,084May 23 04:29 PM
Averick Robert MDirectorMay 17 '23Buy8.651,0208,823364,000May 18 04:02 PM
Averick Robert MDirectorMay 16 '23Buy8.651,48012,802362,980May 18 04:02 PM
Averick Robert MDirectorMay 12 '23Buy8.954,75042,512361,500May 15 04:01 PM
DAIGLE ROBERT CDirectorMay 12 '23Buy8.753,00026,2503,000May 16 04:33 PM
Last Close
Apr 19 04:00PM ET
11.80
Dollar change
+0.46
Percentage change
4.06
%
DVAX Dynavax Technologies Corp. daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.07 Insider Own0.31% Shs Outstand130.62M Perf Week-0.34%
Market Cap1.54B Forward P/E26.65 EPS next Y0.44 Insider Trans-18.85% Shs Float130.21M Perf Month-2.48%
Income-6.39M PEG- EPS next Q-0.02 Inst Own96.91% Short Float13.80% Perf Quarter-15.41%
Sales232.28M P/S6.64 EPS this Y607.60% Inst Trans-1.82% Short Ratio9.38 Perf Half Y-18.90%
Book/sh4.80 P/B2.46 EPS next Y74.44% ROA-0.64% Short Interest17.97M Perf Year7.96%
Cash/sh5.68 P/C2.08 EPS next 5Y- ROE-1.06% 52W Range10.06 - 15.15 Perf YTD-15.59%
Dividend Est.- P/FCF15.98 EPS past 5Y54.52% ROI-0.73% 52W High-22.11% Beta1.30
Dividend TTM- Quick Ratio12.96 Sales past 5Y239.63% Gross Margin78.40% 52W Low17.30% ATR (14)0.30
Dividend Ex-Date- Current Ratio13.81 EPS Y/Y TTM-102.20% Oper. Margin-14.66% RSI (14)43.51 Volatility2.57% 2.25%
Employees408 Debt/Eq0.41 Sales Y/Y TTM-67.86% Profit Margin-2.75% Recom1.40 Target Price25.40
Option/ShortYes / Yes LT Debt/Eq0.41 EPS Q/Q-99.65% Payout- Rel Volume4.85 Prev Close11.34
Sales Surprise5.46% EPS Surprise100.00% Sales Q/Q-69.87% EarningsFeb 22 AMC Avg Volume1.91M Price11.80
SMA20-2.14% SMA50-4.60% SMA200-12.95% Trades Volume9,288,924 Change4.06%
Date Action Analyst Rating Change Price Target Change
Feb-01-24Initiated Goldman Neutral $20
Sep-27-22Initiated JMP Securities Mkt Outperform $22
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
Mar-04-24 11:53PM
08:28PM
Feb-27-24 06:54PM
Feb-23-24 10:34AM
06:38AM
08:00PM Loading…
Feb-22-24 08:00PM
05:15PM
04:44PM
04:01PM
Feb-08-24 04:15PM
Jan-08-24 10:58PM
09:00AM
Jan-05-24 08:50AM
03:03AM
Jan-03-24 06:33PM
09:55AM Loading…
Dec-05-23 09:55AM
Nov-24-23 09:40AM
Nov-20-23 05:04PM
Nov-07-23 09:40AM
Nov-04-23 09:02AM
Nov-03-23 12:28PM
10:46AM
05:31AM
Nov-02-23 06:22PM
04:39PM
04:01PM
11:23AM
Nov-01-23 12:03PM
Oct-30-23 10:00AM
Oct-26-23 04:15PM
12:00PM Loading…
12:00PM
10:02AM
Oct-24-23 07:45AM
Oct-19-23 01:15PM
06:32AM
Oct-16-23 09:55AM
08:50AM
Oct-12-23 10:42AM
Oct-11-23 09:24AM
Oct-05-23 05:01AM
Sep-29-23 09:55AM
08:50AM
Sep-28-23 11:18AM
10:48AM
Sep-26-23 11:49AM
Sep-21-23 09:19AM
Sep-20-23 07:51AM
Sep-18-23 09:16AM
Sep-14-23 09:36AM
Sep-12-23 08:26AM
07:54AM
Sep-11-23 12:31PM
08:21AM
Sep-08-23 07:06PM
Sep-07-23 08:43AM
Sep-06-23 04:05PM
09:33AM
Sep-05-23 09:40AM
Sep-04-23 10:51AM
Aug-28-23 09:55AM
Aug-24-23 08:50AM
Aug-22-23 11:56AM
10:18AM
Aug-16-23 01:21PM
Aug-11-23 05:26AM
Aug-10-23 11:50AM
09:55AM
Aug-07-23 03:06PM
Aug-06-23 07:00AM
Aug-04-23 12:53PM
01:00AM
Aug-03-23 06:55PM
05:45PM
04:05PM
Jul-28-23 02:56PM
Jul-27-23 11:19AM
Jul-20-23 04:15PM
Jul-13-23 03:00PM
Jul-12-23 09:55AM
Jun-21-23 08:00PM
Jun-14-23 10:50AM
Jun-13-23 09:07PM
Jun-01-23 07:52PM
May-30-23 04:15PM
May-08-23 04:15PM
May-03-23 09:42AM
May-02-23 10:00PM
05:35PM
04:37PM
04:05PM
Apr-26-23 08:00PM
Apr-18-23 04:15PM
Apr-09-23 08:52AM
Mar-24-23 06:30AM
Mar-19-23 08:56AM
Mar-01-23 04:15PM
Feb-28-23 08:00AM
Feb-26-23 07:30AM
Feb-24-23 01:00PM
09:24AM
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burgess JustinChief Accounting OfficerMar 01 '24Option Exercise10.457,10174,23220,526Mar 04 05:25 PM
Burgess JustinChief Accounting OfficerMar 01 '24Sale12.7820,526262,3220Mar 04 05:25 PM
Janssen RobertSVP and CMOJan 04 '24Option Exercise9.411,50014,11551,425Jan 08 06:48 PM
Janssen RobertSVP and CMOJan 04 '24Sale15.001,50022,50049,925Jan 08 06:48 PM
Novack David FPresident & COOJan 02 '24Option Exercise5.429,00048,78012,187Jan 04 07:04 PM
Novack David FPresident & COOJan 02 '24Sale14.459,000130,0503,187Jan 04 07:04 PM
Novack David FPresident & COODec 01 '23Option Exercise5.4220,000108,40023,187Dec 05 07:12 PM
Novack David FPresident & COODec 01 '23Sale13.5620,000271,2003,187Dec 05 07:12 PM
Novack David FPresident & COONov 03 '23Option Exercise5.4220,000108,40023,187Nov 07 05:16 PM
Novack David FPresident & COONov 03 '23Sale15.0020,000300,0003,187Nov 07 05:16 PM
Novack David FPresident & COONov 01 '23Option Exercise5.4220,000108,40023,187Nov 03 04:32 PM
Novack David FPresident & COONov 01 '23Sale14.1220,000282,4003,187Nov 03 04:32 PM
Janssen RobertSVP and CMOOct 10 '23Option Exercise9.411,75516,51551,680Oct 11 08:53 PM
Janssen RobertSVP and CMOOct 10 '23Sale15.011,75526,34349,925Oct 11 08:53 PM
Novack David FPresident & COOOct 02 '23Option Exercise5.4240,000216,80043,187Oct 04 04:35 PM
Janssen RobertSVP and CMOOct 02 '23Option Exercise9.415,01547,19154,940Oct 03 08:26 PM
Novack David FPresident & COOOct 02 '23Sale14.8840,000595,0003,187Oct 04 04:35 PM
Janssen RobertSVP and CMOOct 02 '23Sale15.035,01575,37549,925Oct 03 08:26 PM
Novack David FPresident & COOSep 01 '23Option Exercise5.4220,000108,40023,187Sep 05 05:05 PM
Novack David FPresident & COOSep 01 '23Sale14.4820,000289,6003,187Sep 05 05:05 PM
Janssen RobertSVP and CMOAug 24 '23Option Exercise9.416005,64650,525Aug 25 06:47 PM
Janssen RobertSVP and CMOAug 24 '23Sale15.026009,01249,925Aug 25 06:47 PM
Janssen RobertSVP and CMOAug 23 '23Option Exercise9.4134,857328,00484,782Aug 24 12:30 PM
Janssen RobertSVP and CMOAug 23 '23Sale15.0134,857523,20449,925Aug 24 12:30 PM
Novack David FPresident & COOAug 08 '23Option Exercise4.4140,000176,55043,187Aug 10 11:57 AM
Janssen RobertSVP and CMOAug 08 '23Option Exercise9.412,60024,46652,525Aug 09 07:26 PM
Hack Andrew A. F.DirectorAug 08 '23Sale14.391,500,00021,585,000915,000Aug 10 04:31 PM
Novack David FPresident & COOAug 08 '23Sale14.8740,000594,9003,187Aug 10 11:57 AM
Janssen RobertSVP and CMOAug 08 '23Sale15.052,60039,13049,925Aug 09 07:26 PM
Burgess JustinChief Accounting OfficerAug 07 '23Option Exercise8.168,06165,7678,061Aug 08 04:23 PM
Burgess JustinChief Accounting OfficerAug 07 '23Sale14.548,061117,2470Aug 08 04:23 PM
Hack Andrew A. F.DirectorJun 14 '23Sale12.68500,0006,340,0002,415,000Jun 16 04:30 PM
Hack Andrew A. F.DirectorMay 18 '23Sale10.551,000,00010,550,0002,915,000May 19 04:30 PM
Novack David FPresident & COOMay 04 '23Sale10.9017,515190,9143,187May 05 08:58 PM